Trials / Withdrawn
WithdrawnNCT02767349
Pharmacokinetics and Safety of MNK-155 in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Mallinckrodt · Industry
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
An open-label study of the pharmacokinetics (PK) and safety of MNK-155 in postsurgical adolescent subjects aged 12 to 17 years with moderate to severe acute pain. The study will assess the safety of administering multiple doses of MNK-155 in this population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MNK-155 | 2 or 3 tablets initial dose, followed by two tablets every twelve hours |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-04-01
- Completion
- 2017-06-01
- First posted
- 2016-05-10
- Last updated
- 2017-04-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02767349. Inclusion in this directory is not an endorsement.